2 unknown. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Peschke GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer | Phase 2 / Phase 3 | Unknown | Peschke GmbH | 488 | 2022-03-14 | 2022-10-28 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care Therapy + Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer | Phase 2 / Phase 3 | Unknown | Peschke GmbH | 468 | 2022-03-14 | 2022-10-28 |
Corneal Ulcer (2) · Keratitis (2)
Lubricant Eye Drops (2) · Riboflavin (2)
United States (2)
Bala Ambati (2) · Yvette Viscuso (2)